March

Asthma and COVID-19: do we finally have answers? Katrien Eger, Elisabeth H. Bel Eur Respir J, 57 (3) 2004451; 10.1183/13993003.04451-2020
To recline is to relax? Not when you have COPD! David G. Chapman, Gregory G. King Eur Respir J, 57 (3) 2004415; 10.1183/13993003.04415-2020
Cardiac disease from accelerated FEV₁ decline and acute exacerbations: time to rethink comorbidities in COPD Yunus Çolak Eur Respir J, 57 (3) 2004008; 10.1183/13993003.04008-2020
Transitioning from infancy to adulthood: a black box full of opportunities Alvar Agusti, Robab Breyer-Kohansal, Rosa Faner Eur Respir J, 57 (3) 2003997; 10.1183/13993003.03997-2020
Mononuclear phagocytic system and fibrosis: back to the future? Kjetil Ask, Megan Vierhout, Anna Dvorkin-Gheva, Wei Shi Eur Respir J, 57 (3) 2004466; 10.1183/13993003.04466-2020
Regulation of immune cells in lung fibrosis: the reign of regnase-1? Antoine Froidure, Bruno Crestani Eur Respir J, 57 (3) 2004029; 10.1183/13993003.04029-2020
Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry Graham L. Hall, Nicole Filipow, Gregg Ruppel, Tolu Okitika, Bruce Thompson, Jane Kirkby, Irene Steenbruggen, Brendan G. Cooper, Sanja Stanojevic Eur Respir J, 57 (3) 2000289; 10.1183/13993003.00289-2020
European Respiratory Society statement on thoracic ultrasound Christian B. Laursen, Amelia Clive, Rob Hallifax, Pia Iben Pietersen, Rachelle Asciak, Jesper Rømhild Davidsen, Rahul Bhatnagar, Eihab O. Bedawi, Niels Jacobsen, Courtney Coleman, Anthony Edey, Gabriele Via, Giovanni Volpicelli, Gilbert Massard, Francesco Raimondi, Matthew Evison, Lars Konge, Jouke Annema, Najib M. Rahman, Nick Maskell Eur Respir J, 57 (3) 2001519; 10.1183/13993003.01519-2020
Effect of asthma and asthma medication on the prognosis of patients with COVID-19 Yong Jun Choi, Ju-Young Park, Hye Sun Lee, Jin Suh, Jeung Yoon Song, Min Kwang Byun, Jae Hwa Cho, Hyung Jung Kim, Jae-Hyun Lee, Jung-Won Park, Hye Jung Park Eur Respir J, 57 (3) 2002226; 10.1183/13993003.02226-2020
The impact of COVID-19 on patients with asthma José Luis Izquierdo, Carlos Almonacid, Yolanda González, Carlos Del Rio-Bermudez, Julio Ancochea, Remedios Cárdenas, Sara Lumbreras, Joan B. Soriano Eur Respir J, 57 (3) 2003142; 10.1183/13993003.03142-2020
A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD Pei Yee Tiew, Alison J. Dicker, Holly R. Keir, Mau Ern Poh, Sze Lei Pang, Micheál Mac Aogáin, Branden Qi Yu Chua, Jiunn Liang Tan, Huiying Xu, Mariko Siyue Koh, Augustine Tee, John Arputhan Abisheganaden, Fook Tim Chew, Bruce E. Miller, Ruth Tal-Singer, James D. Chalmers, Sanjay H. Chotirmall Eur Respir J, 57 (3) 2002050; 10.1183/13993003.02050-2020
Mechanisms of orthopnoea in patients with advanced COPD Amany F. Elbehairy, Azmy Faisal, Hannah McIsaac, Nicolle J. Domnik, Kathryn M. Milne, Matthew D. James, J. Alberto Neder, Denis E. O'Donnell Eur Respir J, 57 (3) 2000754; 10.1183/13993003.00754-2020
Accelerated FEV₁ decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Hannah R. Whittaker, Chloe Bloom, Ann Morgan, Deborah Jarvis, Steven J. Kiddle, Jennifer K. Quint Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020
Assessment of chronic bronchitis and risk factors in young adults: results from BAMSE Gang Wang, Jenny Hallberg, Petra Um Bergström, Christer Janson, Göran Pershagen, Olena Gruzieva, Marianne van Hage, Antonios Georgelis, Anna Bergström, Inger Kull, Anders Lindén, Erik Melén Eur Respir J, 57 (3) 2002120; 10.1183/13993003.02120-2020
Asthma medication use in obese and healthy weight asthma: systematic review/meta-analysis Cherry A. Thompson, Shaun R. Eslick, Bronwyn S. Berthon, Lisa G. Wood Eur Respir J, 57 (3) 2000612; 10.1183/13993003.00612-2020
The mononuclear phagocyte system contributes to fibrosis in post-transplant obliterans bronchiolitis Maria-Pia Di Campli, Abdulkader Azouz, Assiya Assabban, Jessika Scaillet, Marion Splittgerber, Alexandra Van Keymeulen, Frederick Libert, Myriam Remmelink, Alain Le Moine, Philippe Lemaitre, Stanislas Goriely Eur Respir J, 57 (3) 2000344; 10.1183/13993003.00344-2020
Targeting HIF2a-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension David Macias, Stephen Moore, Alexi Crosby, Mark Southwood, Xinlin Du, Huiling Tan, Shanhai Xie, Arlette Vassallo, Alexander J.T. Wood, Eli M. Wallace, Andrew S. Cowburn Eur Respir J, 57 (3) 1902061; 10.1183/13993003.02061-2019
Profibrotic function of pulmonary group 2 innate lymphoid cells is controlled by regnase-1 Yoshinari Nakatsuka, Ai Yaku, Tomohiro Handa, Alexis Vandenbon, Yuki Hikichi, Yasutaka Motomura, Ayuko Sato, Masanori Yoshinaga, Kiminobu Tanizawa, Kizuku Watanabe, Toyohiro Hirai, Kazuo Chin, Yutaka Suzuki, Takuya Uehata, Takashi Mino, Tohru Tsujimura, Kazuyo Moro, Osamu Takeuchi Eur Respir J, 57 (3) 2000018; 10.1183/13993003.00018-2020
Sleep laboratories reopening and COVID-19: a European perspective Sophia Schiza, Anita Simonds, Winfried Randerath, Francesco Fanfulla, Dries Testelmans, Ludger Grote, Joseph M. Montserrat, Jean-Louis Pepin, Johan Verbraecken, Refika Ersu, Maria R. Bonsignore Eur Respir J, 57 (3) 2002722; 10.1183/13993003.02722-2020
Lung CD4+ T-cells in patients with lung fibrosis produce pro-fibrotic interleukin-13 together with interferon-? Liv I.B. Sikkeland, Shuo-Wang Qiao, Thor Ueland, Ole Myrdal, Lukasz Wyrozemski, Pål Aukrust, Frode L. Jahnsen, Tone Sjåheim, Johny Kongerud, Øyvind Molberg, May Brit Lund, Espen S. Bækkevold Eur Respir J, 57 (3) 2000983; 10.1183/13993003.00983-2020
Suboptimal moxifloxacin and levofloxacin drug exposure during treatment of patients with multidrug-resistant tuberculosis: results from a prospective study in China Lina Davies Forsman, Katarina Niward, Johanna Kuhlin, Xubin Zheng, Rongrong Zheng, Ran Ke, Chao Hong, Jim Werngren, Jakob Paues, Ulrika S.H. Simonsson, Erik Eliasson, Sven Hoffner, Biao Xu, Jan-Willem Alffenaar, Thomas Schön, Yi Hu, Judith Bruchfeld Eur Respir J, 57 (3) 2003463; 10.1183/13993003.03463-2020
Plasma mediators in patients with severe COVID-19 cause lung endothelial barrier failure Laura Michalick, Sarah Weidenfeld, Benjamin Grimmer, Diana Fatykhova, Philip Daniel Solymosi, Felix Behrens, Melanie Dohmen, Markus C. Brack, Sabrina Schulz, Elisa Thomasch, Szandor Simmons, Holger Müller-Redetzky, Norbert Suttorp, Florian Kurth, Jens Neudecker, Mario Toennies, Torsten T. Bauer, Stephan Eggeling, Victor Max Corman, Andreas C. Hocke, Martin Witzenrath, Stefan Hippenstiel, Wolfgang M. Kuebler Eur Respir J, 57 (3) 2002384; 10.1183/13993003.02384-2020
Concurrent use of bedaquiline and delamanid for the treatment of fluoroquinolone-resistant multidrug-resistant tuberculosis: a nationwide cohort study in South Korea Yong-Soo Kwon, Doosoo Jeon, Hyungseok Kang, Jae-Joon Yim, Tae Sun Shim Eur Respir J, 57 (3) 2003026; 10.1183/13993003.03026-2020
Leukocyte telomere length and mycophenolate therapy in chronic hypersensitivity pneumonitis Ayodeji Adegunsoye, Julie Morisset, Chad A. Newton, Justin M. Oldham, Eric Vittinghoff, Angela L. Linderholm, Mary E. Strek, Imre Noth, Christine Kim Garcia, Paul J. Wolters, Brett Ley Eur Respir J, 57 (3) 2002872; 10.1183/13993003.02872-2020
Clump material within drainage chest tubes contains diagnostic information: a proof-of-concept case series Amber Louw, Calvin Sidhu, Deirdre B. Fitzgerald, Jenette Creaney, Siaw Ming Chai, Y.C. Gary Lee Eur Respir J, 57 (3) 2003248; 10.1183/13993003.03248-2020
Noxious cold stimulation: pro–con perspectives on the hypothermic effect on experimentally evoked cough Shuxin Zhong, Liman Fang, Zhe Chen, Chen Zhan, S. Dushinka de Silva, Kefang Lai, Ruchong Chen Eur Respir J, 57 (3) 2004063; 10.1183/13993003.04063-2020
Reply to: Noxious cold stimulation: pro–con perspectives on the hypothermic effect on experimentally evoked cough Imran Satia, Emma Iovoli, Kimberley Holt, Ashley A. Woodcock, John Belcher, Jaclyn A. Smith Eur Respir J, 57 (3) 2100245; 10.1183/13993003.00245-2021
Fixed breathing protocols in multiple-breath-washout testing: truly an option in children? Anne-Christianne Kentgens, Philipp Latzin, Sophie Yammine Eur Respir J, 57 (3) 2100001; 10.1183/13993003.00001-2021
Reply: Fixed breathing protocols in multiple-breath-washout testing: truly an option in children? Sylvia Verbanck, Daniel Schuermans, Manuel Paiva, Paul D. Robinson, Eef Vanderhelst Eur Respir J, 57 (3) 2100189; 10.1183/13993003.00189-2021
Connecting the dots: the role of connexins in the pulmonary vascular response to hypoxia Martin Witzenrath, Wolfgang M. Kuebler Eur Respir J, 57 (3) 2004573; 10.1183/13993003.04573-2020
Retraction notice for: “Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases.” Theodoros V. Giannouchos, Roberto A. Sussman, José M. Mier, Konstantinos Poulas and Konstantinos Farsalinos. Eur Respir J 2020; in press. Eur Respir J, 57 (3) 2002144; 10.1183/13993003.02144-2020
The clear and persistent impact of air pollution on chronic respiratory diseases: a call for interventions Isabella Annesi-Maesano, Francesco Forastiere, John Balmes, Erika Garcia, Jack Harkema, Stephen Holgate, Frank Kelly, Haneen Khreis, Barbara Hoffmann, Cara Nichole Maesano, Rob McConnell, David Peden, Kent Pinkerton, Tamara Schikowski, George Thurston, Laura S. Van Winkle, Christopher Carlsten Eur Respir J, 57 (3) 2002981; 10.1183/13993003.02981-2020
Transthoracic shear wave ultrasound: a noninvasive tool to differentiate between benign and malignant subpleural lung lesions Johny A. Verschakelen Eur Respir J, 57 (3) 2004260; 10.1183/13993003.04260-2020
Targeted next-generation sequencing: a Swiss army knife for mycobacterial diagnostics? Sagal Mohamed, Claudio U. Köser, Max Salfinger, Wladimir Sougakoff, Scott K. Heysell Eur Respir J, 57 (3) 2004077; 10.1183/13993003.04077-2020
COPD: still an unpredictable journey Alex Bottle, Jenni Quint Eur Respir J, 57 (3) 2002933; 10.1183/13993003.02933-2020
Socioeconomic disadvantage and lung health: accumulating evidence to support health policy Sanja Stanojevic Eur Respir J, 57 (3) 2004025; 10.1183/13993003.04025-2020
Application of transthoracic shear-wave ultrasound elastography in lung lesions Yao-Wen Kuo, Yen-Lin Chen, Huey-Dong Wu, Ying-Chun Chien, Chun-Kai Huang, Hao-Chien Wang Eur Respir J, 57 (3) 2002347; 10.1183/13993003.02347-2020
Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs Agathe Jouet, Cyril Gaudin, Nelly Badalato, Caroline Allix-Béguec, Stéphanie Duthoy, Alice Ferré, Maren Diels, Yannick Laurent, Sandy Contreras, Silke Feuerriegel, Stefan Niemann, Emmanuel André, Michel K. Kaswa, Elisa Tagliani, Andrea Cabibbe, Vanessa Mathys, Daniela Cirillo, Bouke C. de Jong, Leen Rigouts, Philip Supply Eur Respir J, 57 (3) 2002338; 10.1183/13993003.02338-2020
Evaluation of the latent tuberculosis screening and treatment strategy for asylum seekers in Stockholm, Sweden 2015–2018: a record linkage study of the care cascade Joanna Nederby Öhd, Maria-Pia Hergens, Yauheni Luksha, Charlotte Buxbaum, Jad Shedrawy, Jerker Jonsson, Judith Bruchfeld, Knut Lönnroth Eur Respir J, 57 (3) 2002255; 10.1183/13993003.02255-2020
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort Bartolome Celli, Nicholas Locantore, Julie C. Yates, Per Bakke, Peter M.A. Calverley, Courtney Crim, Harvey O. Coxson, David A. Lomas, William MacNee, Bruce E. Miller, Hana Mullerova, Stephen I. Rennard, Edwin K. Silverman, Emiel Wouters, Ruth Tal-Singer, Alvar Agusti, Jørgen Vestbo Eur Respir J, 57 (3) 2001339; 10.1183/13993003.01339-2020
Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials Kevin Wing, Elizabeth Williamson, James R. Carpenter, Lesley Wise, Sebastian Schneeweiss, Liam Smeeth, Jennifer K. Quint, Ian Douglas Eur Respir J, 57 (3) 2001586; 10.1183/13993003.01586-2020
Life-course socioeconomic disadvantage and lung function: a multicohort study of 70?496 individuals Vânia Rocha, Sílvia Fraga, Carla Moreira, Cristian Carmeli, Alexandra Lenoir, Andrew Steptoe, Graham Giles, Marcel Goldberg, Marie Zins, Mika Kivimäki, Paolo Vineis, Peter Vollenweider, Henrique Barros, Silvia Stringhini Eur Respir J, 57 (3) 2001600; 10.1183/13993003.01600-2020
Temporal airway microbiome changes related to ventilator-associated pneumonia in children Peter M. Mourani, Marci K. Sontag, Kayla M. Williamson, J. Kirk Harris, Ron Reeder, Chris Locandro, Todd C. Carpenter, Aline B. Maddux, Katherine Ziegler, Eric A.F. Simões, Christina M. Osborne, Lilliam Ambroggio, Matthew K. Leroue, Charles E. Robertson, Charles Langelier, Joseph L. DeRisi, Jack Kamm, Mark W. Hall, Athena F. Zuppa, Joseph Carcillo, Kathleen Meert, Anil Sapru, Murray M. Pollack, Patrick McQuillen, Daniel A. Notterman, J. Michael Dean, Brandie D. Wagner Eur Respir J, 57 (3) 2001829; 10.1183/13993003.01829-2020
Phagosome-regulated mTOR signalling during sarcoidosis granuloma biogenesis Elliott D. Crouser, Landon W. Locke, Mark W. Julian, Sabahattin Bicer, Wolfgang Sadee, Peter White, Larry S. Schlesinger Eur Respir J, 57 (3) 2002695; 10.1183/13993003.02695-2020
Solitary pulmonary nodule imaging approaches and the role of optical fibre-based technologies Susan Fernandes, Gareth Williams, Elvira Williams, Katjana Ehrlich, James Stone, Neil Finlayson, Mark Bradley, Robert R. Thomson, Ahsan R. Akram, Kevin Dhaliwal Eur Respir J, 57 (3) 2002537; 10.1183/13993003.02537-2020
Hypoxic burden and heart rate variability predict stroke incidence in sleep apnoea Margaux Blanchard, Chloé Gervès-Pinquié, Mathieu Feuilloy, Marc Le Vaillant, Wojciech Trzepizur, Nicole Meslier, François Goupil, Thierry Pigeanne, Frédéric Balusson, Emmanuel Oger, AbdelKebir Sabil, Jean-Marc Girault, Frédéric Gagnadoux Eur Respir J, 57 (3) 2004022; 10.1183/13993003.04022-2020
Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months: follow-up of a longitudinal clinical study Magnus Ekström, Hans Bornefalk, C. Magnus Sköld, Christer Janson, Anders Blomberg, Jacob Sandberg, Anna Bornefalk-Hermansson, David C. Currow, Miriam J. Johnson, Josefin Sundh Eur Respir J, 57 (3) 2002823; 10.1183/13993003.02823-2020
Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation Spyros A. Papiris, Demosthenes Bouros, Katerina Markopoulou, Lykourgos Kolilekas, Andriana I. Papaioannou, Vasilios Tzilas, Argyrios Tzouvelekis, Eva Fouka, Despoina Papakosta, Zoe Daniil, Paschalis Steiropoulos, Athina Gogali, Ilias C. Papanikolaou, Areti Xyfteri, Aggeliki Haritou, Ioanna Korbila, Ioannis P. Tomos, Stylianos Loukides, Rita Bellelli, Georgia Kounti, Christina Rampiadou, Theodoros Karampitsakos, Ilias Dimeas, Paraskevi Kirgou, Andromachi Bompoki, Eirini Vasarmidi, Konstantinos Loverdos, Elvira-Markela Antonogiannaki, Myrto Blizou, Evangelos Bouros, Konstantinos Kagouridis, Maria Maniati, Anna Karakatsani, Katerina M. Antoniou, Effrosyni D. Manali Eur Respir J, 57 (3) 2003111; 10.1183/13993003.03111-2020
Exploratory study of the effectiveness of nebulised saline in children with neurodisability Natalia Galaz Souza, Andrew Bush, Hui-Leng Tan Eur Respir J, 57 (3) 2001407; 10.1183/13993003.01407-2020
Effect of non-uniform cyst distribution in lymphangioleiomyomatosis on pulmonary function: a cross-sectional study Amir M. Hasani, Brianna Matthew, Mahshid Goljamali, Yun-Ching Chen, Mario Stylianou, Mehdi Pirooznia, Angelo Taveira-DaSilva, Marcus Y. Chen, Han Wen, Joel Moss Eur Respir J, 57 (3) 2003769; 10.1183/13993003.03769-2020
Examining the intubation decision in randomised clinical trials Aiman Tulaimat Eur Respir J, 57 (3) 2100051; 10.1183/13993003.00051-2021
P_aO₂/F_IO₂ ratio: the mismeasure of oxygenation in COVID-19 Martin J. Tobin, Amal Jubran, Franco Laghi Eur Respir J, 57 (3) 2100274; 10.1183/13993003.00274-2021
Mortality benefit with antifibrotics in idiopathic pulmonary fibrosis: real world evidence or bias? Samy Suissa, Deborah Assayag Eur Respir J, 57 (3) 2004562; 10.1183/13993003.04562-2020
Comment on: Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis Jakob Borchardt Eur Respir J, 57 (3) 2004645; 10.1183/13993003.04645-2020
Reply: Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis Jürgen Behr, David Pittrow, Jens Klotsche Eur Respir J, 57 (3) 2100283; 10.1183/13993003.00283-2021
“The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment.” Silvia Ulrich and Ekkehard Grunig. Eur Respir J 2021; 57: 2004376 Eur Respir J, 57 (3) 2054376; 10.1183/13993003.54376-2020